CTNM — Contineum Therapeutics, Inc. stock price, charts and financials

QT84Contineum Therapeutics, Inc.

Contineum Therapeutics, Inc. (NASDAQ: CTNM) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
15.90
-0.03-0.19%
OverviewShort InterestFilings
CTNMQT84Contineum Therapeutics, Inc.·NASDAQ
15.90-0.19%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 03, 20264Statement of changes in beneficial ownership
Jul 30, 202610-QQuarterly report
Jul 30, 20268-KCurrent report
Jul 27, 2026SC 13GBeneficial ownership statement (passive)
Jul 17, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 13, 20268-KCurrent report
Jul 10, 20264Statement of changes in beneficial ownership
Jul 08, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jun 26, 20268-KCurrent report
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 05, 202610-QQuarterly report
May 05, 20268-KCurrent report
May 01, 20264Statement of changes in beneficial ownership
#1 / 25 of 169
Page
▼
/ 7